Patent · US Active

Methods and systems for glucose regulation

US8483830B2 · kind B2 · utility

28Cited by
12References
38Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 3, 2009
Grant dateJul 9, 2013
Priority date
Expiry dateNov 16, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N1/37235
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Various methods and apparatus for treating a condition associated with impaired glucose regulation in a subject comprising in one embodiment, applying a neural conduction block to a target nerve at a blocking site with the neural conduction block selected to at least partially block nerve pulses. In another embodiment, combinations of down-regulating and or up-regulating with or without pharmaceutical agents are used to treat impaired glucose regulation. In other embodiments, up-regulation or down-regulation of various nerves, such as the vagus and its branches, and the splanchnic is used to modify the production of GLP-1 and GIP, thereby controlling glucose levels. In yet further embodiments, combinations of down-regulating and or up-regulating with or without pharmaceutical agents are used to modify the production of GLP-1 and GIP, to treat impaired glucose regulation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.